Your browser doesn't support javascript.
loading
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation.
Costa, Bruno Almeida; Tallón de Lara, Paulino; Park, Wungki; Keane, Fergus; Harding, James J; Khalil, Danny N.
Affiliation
  • Costa BA; Department of Medicine, Icahn School of Medicine at Mount Sinai (Morningside/West), New York, New York, USA, bruno.costa@mountsinai.org.
  • Tallón de Lara P; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Park W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Keane F; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Khalil DN; Department of Medicine, Weill Medical College of Cornell University, New York, New York, USA.
Oncol Res Treat ; 46(5): 211-215, 2023.
Article in En | MEDLINE | ID: mdl-36882017
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Bile Duct Neoplasms / Klatskin Tumor Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Oncol Res Treat Year: 2023 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Bile Duct Neoplasms / Klatskin Tumor Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Oncol Res Treat Year: 2023 Document type: Article Country of publication: Switzerland